Wednesday, September 27th, 2023
InTray GC Takes the Lead in Gonorrhea Infection Detection
CARLSBAD, Calif.—InTray GC, an innovative culture diagnostic for the detection of gonorrhea with a Class II designation from the U.S. FDA, has filled a critical public health void following the discontinuation of the Remel JEMBEC product by the manufacturer.
InTray GC plays a crucial role in the timely and precise identification of Neisseria gonorrhoeae, the bacteria behind the widespread sexually transmitted infection, gonorrhea. The device is engineered to handle the collection, transport, and growth of Neisseria gonorrhoeae, providing a trustworthy resource for healthcare providers in the ongoing fight against STIs.
The product is developed and sold by Biomed Diagnostics, a pioneer in microbiological testing that develops user-friendly tools to detect infectious microorganisms.
InTray GC's features include:
InTray GC is readily available for order and discounts are available for bulk purchases. Request a sample for evaluation or learn more here.
About Biomed Diagnostics, a DCN Dx Brand
Biomed Diagnostics, a DCN Dx brand, is a pioneer in microbiological testing. It develops innovative, user-friendly tools that detect infectious microorganisms in humans, animals, food, and the environment. The company's InTray and InPouch formats streamline the processes of specimen collection, culture, and transport into a single device. Biomed Diagnostics is committed to impactful health solutions in veterinary, human health, food safety, and environmental markets.
For more information, visit biomeddiagnostics.com.
About DCN Dx
DCN Dx, based in Carlsbad, California, is a global leader in IVD CDMO and CRO services. Our multidisciplinary team specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays.
Our personalized approach to IVD product development has supported more than 560 programs from over 260 clients. We can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, our clinical research expertise extends to a wide range of IVD devices, all with a focus on innovation, usability, and performance.
With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit dcndx.com.
For more information contact:
Chief Revenue Officer, DCN Dx
Main: (760) 804-3886
Mobile: (512) 431-5836